A series of articles that set out to explore the global distribution of infections that cause non-malarial febrile illness (NMFI) has today been published in BMC Medicine.The series brings together the results of large-scale systematic reviews of the causes of fever in Africa, Latin America, and Sou...

We are delighted to announce that Professor Paul Newton has won the Helen-Clark-JoPPP Award for Pharmaceutical Policy and Practice Research. Professor Newton has been presented with the award based on the scientific merit of his work, as well as its impact on patients, decisions makers, and on g...

Research Malaria Microscopy Standards (ReMMS) applicable to malaria clinical research studies have been published in Malaria Journal. The paper describes the rationale for proposed standards to prepare, stain and examine blood films for malaria parasites.

The Medicine Quality Research Group has published a six-month Medical Product Quality Report focused on COVID-19 today, using its Medicine Quality Monitoring Globe tool. New reports will be issued monthly from now on, following the first January - June publication.

New resources are available now on IDDO’s website for COVID-19 researchers. The resources will guide researchers in the collection of ECG data, and the collection, processing and transport of blood pharmacokinetic samples and data.

A major challenge in preventing, detecting and responding to substandard and falsified (SF) medical products is the lack of accessible and reliable information on how widespread the problem is and where. SF medical products, which includes medicines, vaccines, diagnostic tests and devices, pose an i...

Nominations for members of the COVID-19 Data Platform Data Access Committee are now open. Please consider nominating individuals to contribute expertise to this pioneering collaboration in COVID-19 and emerging infections research to covid19@iddo.org by 31 July 2020.

The International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC) is producing a weekly report using clinical data from its COVID-19 database. To date, this includes data from 67,130 individuals from 488 sites across 37 countries.

It is with great sadness that IDDO has learnt of the passing of Professor Marleen Boelaert, a valued member of the IDDO team since 2017. Professor Boelaert’s research concentrated on the control of tropical infectious diseases, mainly leishmaniasis and sleeping sickness.

A first of its kind collaborative open access library to support the global malaria research effort is now available.

IDDO has extended the feedback period on its draft Research Agenda on schistosomiasis and soil-transmitted helminthiases (STHs) until July 17. Comments are welcome from the wider research community to help form the direction of research work using IDDO’s schistosomiasis and STHs data platform.

Visceral leishmaniasis (VL), also known as kala-azar, is transmitted to humans through the bites from infected female phlebotomine sand flies. If left untreated, it is fatal in 95% of cases. Globally, it is estimated there are up to 22,000 new cases of VL each year which occur in Brazil, Ethiopia, I...

The research, published today in The Lancet Infectious Diseases is the fruit of joint project between investigators from around the world to conduct the largest individual patient data meta-analysis to date under the WWARN umbrella. The study found that artemether-lumefantrine (AL) and other artemis...

IDDO is proud to be part of the CDISC task force who rapidly developed the newly released Interim User Guide to support the Covid-19 research community.

Recently a newly formed site team in Malawi used the WWARN Malaria Clinical Trials Toolkit for their antimalarial-antiretroviral drug-drug interaction trial with pregnant women (IMPROVE DDI).

IDDO has published a draft Research Agenda for open review on schistosomiasis and soil-transmitted helminthiases (STHs) for feedback and comments from the wider research community until June 4, 2020.

Global health experts have united in a call for governments and international organisations around the world to plan strategically for the coordinated production, equitable distribution and surveillance of COVID-19 medical products to ensure access to quality-assured medications for everyone.

A group of scientists, physicians, funders, and policy makers from over 70 institutions from over 30 countries have launched an international coalition to respond to COVID-19 in resource-poor settings. The COVID-19 Clinical Research Coalition aims to accelerate desperately needed COVID-19 research i...

The problem of substandard and falsified (SF) medical products affects all countries but few regulatory authorities or pharmaceutical companies have policies of publicly releasing data.